Latest stories on BCLI
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) files 8-K: Items 2.02, 9.01
SEC 8-K50 · neutralgeneral
BrainStorm Cell Therapeutics GAAP EPS of -$0.68 misses by $0.50
Seeking Alpha31 · bearishearnings
BrainStorm Cell Therapeutics Announces Third Quarter 2026 Financial Results and Provides Corporate Update
PR Newswire50 · neutralearnings
BrainStorm Cell Therapeutics GAAP EPS of -$0.35
Seeking Alpha34 · bearishearnings
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) files 8-K
SEC 8-K50 · neutralgeneral
BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update
PR Newswire50 · neutralgeneral
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) files 8-K
SEC 8-K50 · neutralgeneral
BrainStorm Appoints Former FDA Associate Commissioner Peter J. Pitts as Executive Chairman
StockTitan55 · neutralgeneral
BrainStorm Adds Former FDA Leader to Board
TipRanks63 · neutralgeneral
Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration
PR Newswire63 · neutralproduct/pr
BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market
PR Newswire28 · bearishgeneral
BrainStorm Cell Therapeutics GAAP EPS of -$0.19 beats by $0.17
Seeking Alpha56 · neutralearnings
BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
PR Newswire50 · neutralgeneral